Related Experiment Videos
Management of essential hypertension in the black patient: profiling as the initial approach to treatment
Insights
Hypertensive cardiovascular disease presents unique challenges in Black populations due to differing pathophysiology and treatment responses. Tailoring antihypertensive drugs, like calcium channel blockers, to individual patient profiles improves outcomes and reduces adverse effects.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Hypertensive cardiovascular disease pathophysiology and progression vary significantly between Black and non-Black populations.
- Black individuals often exhibit distinct hemodynamic and endocrine profiles, leading to more severe hypertension consequences.
- Standard antihypertensive treatments may be less effective in Black patients, necessitating tailored therapeutic approaches.
Purpose of the Study:
- To investigate the specific pathophysiologic abnormalities in hypertensive cardiovascular disease within the Black population.
- To determine effective antihypertensive treatment strategies tailored to the unique characteristics of Black patients.
- To evaluate the efficacy and safety of specific drug classes, such as calcium channel blockers, in managing hypertension in Black individuals.
Main Methods:
- Analysis of hemodynamic and endocrine profiles in Black patients with hypertensive cardiovascular disease.
- Comparison of treatment responses to standard antihypertensive therapies versus targeted drug selection.
- Assessment of cardiovascular outcomes and adverse effects based on individualized pharmacologic interventions.
Main Results:
- Significant differences in pathophysiology and disease course observed in Black versus non-Black populations.
- Black patients demonstrated reduced responsiveness to certain standard antihypertensive medications.
- Targeted drug therapy, matching drug pharmacologic effects to patient pathophysiology, improved blood pressure control with fewer adverse effects.
- Calcium channel blockers were identified as particularly suitable for treating essential hypertension in Black patients.
Conclusions:
- Personalized antihypertensive drug therapy, addressing specific pathophysiologic abnormalities, is crucial for effective management in Black patients.
- Matching antihypertensive agents to individual patient profiles optimizes blood pressure control and minimizes adverse events.
- Calcium channel blockers represent a well-suited therapeutic option for essential hypertension in the Black population, improving target organ function.
Abstract:
The pathophysiology and course of hypertensive cardiovascular disease in the black population differ significantly from those of nonblacks. The hemodynamic and endocrine profiles are different, consequences of hypertension are more severe in blacks, and black patients are often less responsive to standard antihypertensive treatment. Safe and efficacious treatment can be achieved when drug therapy is directed at the specific underlying pathophysiologic abnormality in black patients. By closely matching cardiovascular pathophysiologic findings in a given patient with the pharmacologic effects of an antihypertensive agent, blood pressure can often be controlled with fewer adverse effects. In addition, blood flow to target organs and their function can be maintained or improved. Calcium channel blockers are especially well suited for the treatment of essential hypertension in black patients.